The article highlights the significant issue of antibiotic resistance, which has led to increased mortality and limited new antibiotic developments. Historically, antibiotics were revolutionary, exemplified by penicillin’s success. However, bacteria have evolved resistance, rendering some antibiotics ineffective and creating a critical public health challenge. Kinvard Bio has emerged from Harvard University with a focus on creating a novel class of antibiotics that could potentially tackle these resistant infections, emphasizing the urgent need for innovative treatments in the medical field.
"We are fighting against a growing tide of antibiotic resistance, making the discovery of new treatments more crucial than ever to save lives affected by resistant infections."
"Current antibiotics are losing their effectiveness against a rising number of pathogens, necessitating innovative strategies and new treatments to combat these health threats."
Collection
[
|
...
]